Serveur d'exploration sur la glutarédoxine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

PEP-1-GLRX1 protein exhibits anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB pathways in Raw 264.7 cells.

Identifieur interne : 000035 ( Main/Exploration ); précédent : 000034; suivant : 000036

PEP-1-GLRX1 protein exhibits anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB pathways in Raw 264.7 cells.

Auteurs : Min Jea Shin [Corée du Sud] ; Dae Won Kim [Corée du Sud] ; Yeon Joo Choi [Corée du Sud] ; Hyun Ju Cha [Corée du Sud] ; Sung Ho Lee [Corée du Sud] ; Jinseu Park [Corée du Sud] ; Kyu Hyung Han [Corée du Sud] ; Won Sik Eum [Corée du Sud] ; Soo Young Choi [Corée du Sud]

Source :

RBID : pubmed:31964467

Descripteurs français

English descriptors

Abstract

Glutaredoxin 1 (GLRX1) has been recognized as an important regulator of redox signaling. Although GLRX1 plays an essential role in cell survival as an antioxidant protein, the function of GLRX1 protein in inflammatory response is still under investigation. Therefore, we wanted to know whether transduced PEP-1-GLRX1 protein inhibits lipopolysaccharide (LPS)- and 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced inflammation. In LPS-exposed Raw 264.7 cells, PEP-1-GLRX1 inhibited cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), activation of mitogen activated protein kinases (MAPKs) and nuclear factor-kappaB (NF-κB) expression levels. In a TPA-induced mouse-ear edema model, topically applied PEP-1-GLRX1 transduced into ear tissues and significantly ameliorated ear edema. Our data reveal that PEP-1-GLRX1 attenuates inflammation in vitro and in vivo, suggesting that PEP-1-GLRX1 may be a potential therapeutic protein for inflammatory diseases. [BMB Reports 2020; 53(2): 106-111].

PubMed: 31964467
PubMed Central: PMC7061214


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">PEP-1-GLRX1 protein exhibits anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB pathways in Raw 264.7 cells.</title>
<author>
<name sortKey="Shin, Min Jea" sort="Shin, Min Jea" uniqKey="Shin M" first="Min Jea" last="Shin">Min Jea Shin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kim, Dae Won" sort="Kim, Dae Won" uniqKey="Kim D" first="Dae Won" last="Kim">Dae Won Kim</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457</wicri:regionArea>
<wicri:noRegion>Gangneung 25457</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Choi, Yeon Joo" sort="Choi, Yeon Joo" uniqKey="Choi Y" first="Yeon Joo" last="Choi">Yeon Joo Choi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cha, Hyun Ju" sort="Cha, Hyun Ju" uniqKey="Cha H" first="Hyun Ju" last="Cha">Hyun Ju Cha</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lee, Sung Ho" sort="Lee, Sung Ho" uniqKey="Lee S" first="Sung Ho" last="Lee">Sung Ho Lee</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252; Genesen Inc., Seoul 06181, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252; Genesen Inc., Seoul 06181</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Park, Jinseu" sort="Park, Jinseu" uniqKey="Park J" first="Jinseu" last="Park">Jinseu Park</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Han, Kyu Hyung" sort="Han, Kyu Hyung" uniqKey="Han K" first="Kyu Hyung" last="Han">Kyu Hyung Han</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Eum, Won Sik" sort="Eum, Won Sik" uniqKey="Eum W" first="Won Sik" last="Eum">Won Sik Eum</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Choi, Soo Young" sort="Choi, Soo Young" uniqKey="Choi S" first="Soo Young" last="Choi">Soo Young Choi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:31964467</idno>
<idno type="pmid">31964467</idno>
<idno type="pmc">PMC7061214</idno>
<idno type="wicri:Area/Main/Corpus">000088</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000088</idno>
<idno type="wicri:Area/Main/Curation">000088</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000088</idno>
<idno type="wicri:Area/Main/Exploration">000088</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">PEP-1-GLRX1 protein exhibits anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB pathways in Raw 264.7 cells.</title>
<author>
<name sortKey="Shin, Min Jea" sort="Shin, Min Jea" uniqKey="Shin M" first="Min Jea" last="Shin">Min Jea Shin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kim, Dae Won" sort="Kim, Dae Won" uniqKey="Kim D" first="Dae Won" last="Kim">Dae Won Kim</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457</wicri:regionArea>
<wicri:noRegion>Gangneung 25457</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Choi, Yeon Joo" sort="Choi, Yeon Joo" uniqKey="Choi Y" first="Yeon Joo" last="Choi">Yeon Joo Choi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cha, Hyun Ju" sort="Cha, Hyun Ju" uniqKey="Cha H" first="Hyun Ju" last="Cha">Hyun Ju Cha</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lee, Sung Ho" sort="Lee, Sung Ho" uniqKey="Lee S" first="Sung Ho" last="Lee">Sung Ho Lee</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252; Genesen Inc., Seoul 06181, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252; Genesen Inc., Seoul 06181</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Park, Jinseu" sort="Park, Jinseu" uniqKey="Park J" first="Jinseu" last="Park">Jinseu Park</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Han, Kyu Hyung" sort="Han, Kyu Hyung" uniqKey="Han K" first="Kyu Hyung" last="Han">Kyu Hyung Han</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Eum, Won Sik" sort="Eum, Won Sik" uniqKey="Eum W" first="Won Sik" last="Eum">Won Sik Eum</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Choi, Soo Young" sort="Choi, Soo Young" uniqKey="Choi S" first="Soo Young" last="Choi">Soo Young Choi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252</wicri:regionArea>
<wicri:noRegion>Chuncheon 24252</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMB reports</title>
<idno type="eISSN">1976-670X</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Anti-Inflammatory Agents (pharmacology)</term>
<term>Cyclooxygenase 2 (metabolism)</term>
<term>Cyclooxygenase 2 Inhibitors (pharmacology)</term>
<term>Cysteamine (analogs & derivatives)</term>
<term>Edema (chemically induced)</term>
<term>Edema (metabolism)</term>
<term>Edema (therapy)</term>
<term>Glutaredoxins (pharmacology)</term>
<term>Inflammation (metabolism)</term>
<term>Lipopolysaccharides (pharmacology)</term>
<term>Male (MeSH)</term>
<term>Mice (MeSH)</term>
<term>Mice, Inbred ICR (MeSH)</term>
<term>Mitogen-Activated Protein Kinases (antagonists & inhibitors)</term>
<term>Mitogen-Activated Protein Kinases (metabolism)</term>
<term>NF-kappa B (metabolism)</term>
<term>Nitric Oxide Synthase Type II (antagonists & inhibitors)</term>
<term>Nitric Oxide Synthase Type II (metabolism)</term>
<term>Peptides (MeSH)</term>
<term>Phosphorylation (MeSH)</term>
<term>RAW 264.7 Cells (MeSH)</term>
<term>Signal Transduction (drug effects)</term>
<term>Tetradecanoylphorbol Acetate (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>12-Myristate-13-acétate de phorbol (pharmacologie)</term>
<term>Animaux (MeSH)</term>
<term>Anti-inflammatoires (pharmacologie)</term>
<term>Cellules RAW 264.7 (MeSH)</term>
<term>Cyclooxygenase 2 (métabolisme)</term>
<term>Facteur de transcription NF-kappa B (métabolisme)</term>
<term>Glutarédoxines (pharmacologie)</term>
<term>Inflammation (métabolisme)</term>
<term>Inhibiteurs de la cyclooxygénase 2 (pharmacologie)</term>
<term>Lipopolysaccharides (pharmacologie)</term>
<term>Mercaptamine (analogues et dérivés)</term>
<term>Mitogen-Activated Protein Kinases (antagonistes et inhibiteurs)</term>
<term>Mitogen-Activated Protein Kinases (métabolisme)</term>
<term>Mâle (MeSH)</term>
<term>Nitric oxide synthase type II (antagonistes et inhibiteurs)</term>
<term>Nitric oxide synthase type II (métabolisme)</term>
<term>Oedème (induit chimiquement)</term>
<term>Oedème (métabolisme)</term>
<term>Oedème (thérapie)</term>
<term>Peptides (MeSH)</term>
<term>Phosphorylation (MeSH)</term>
<term>Souris (MeSH)</term>
<term>Souris de lignée ICR (MeSH)</term>
<term>Transduction du signal (effets des médicaments et des substances chimiques)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Cysteamine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Mitogen-Activated Protein Kinases</term>
<term>Nitric Oxide Synthase Type II</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Cyclooxygenase 2</term>
<term>Mitogen-Activated Protein Kinases</term>
<term>NF-kappa B</term>
<term>Nitric Oxide Synthase Type II</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Anti-Inflammatory Agents</term>
<term>Cyclooxygenase 2 Inhibitors</term>
<term>Glutaredoxins</term>
<term>Lipopolysaccharides</term>
<term>Tetradecanoylphorbol Acetate</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>Mercaptamine</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Mitogen-Activated Protein Kinases</term>
<term>Nitric oxide synthase type II</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Edema</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Transduction du signal</term>
</keywords>
<keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr">
<term>Oedème</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Edema</term>
<term>Inflammation</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Cyclooxygenase 2</term>
<term>Facteur de transcription NF-kappa B</term>
<term>Inflammation</term>
<term>Mitogen-Activated Protein Kinases</term>
<term>Nitric oxide synthase type II</term>
<term>Oedème</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>12-Myristate-13-acétate de phorbol</term>
<term>Anti-inflammatoires</term>
<term>Glutarédoxines</term>
<term>Inhibiteurs de la cyclooxygénase 2</term>
<term>Lipopolysaccharides</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Edema</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Oedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred ICR</term>
<term>Peptides</term>
<term>Phosphorylation</term>
<term>RAW 264.7 Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules RAW 264.7</term>
<term>Mâle</term>
<term>Peptides</term>
<term>Phosphorylation</term>
<term>Souris</term>
<term>Souris de lignée ICR</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Glutaredoxin 1 (GLRX1) has been recognized as an important regulator of redox signaling. Although GLRX1 plays an essential role in cell survival as an antioxidant protein, the function of GLRX1 protein in inflammatory response is still under investigation. Therefore, we wanted to know whether transduced PEP-1-GLRX1 protein inhibits lipopolysaccharide (LPS)- and 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced inflammation. In LPS-exposed Raw 264.7 cells, PEP-1-GLRX1 inhibited cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), activation of mitogen activated protein kinases (MAPKs) and nuclear factor-kappaB (NF-κB) expression levels. In a TPA-induced mouse-ear edema model, topically applied PEP-1-GLRX1 transduced into ear tissues and significantly ameliorated ear edema. Our data reveal that PEP-1-GLRX1 attenuates inflammation in vitro and in vivo, suggesting that PEP-1-GLRX1 may be a potential therapeutic protein for inflammatory diseases. [BMB Reports 2020; 53(2): 106-111].</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">31964467</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>06</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>06</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1976-670X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>53</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2020</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>BMB reports</Title>
<ISOAbbreviation>BMB Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>PEP-1-GLRX1 protein exhibits anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB pathways in Raw 264.7 cells.</ArticleTitle>
<Pagination>
<MedlinePgn>106-111</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Glutaredoxin 1 (GLRX1) has been recognized as an important regulator of redox signaling. Although GLRX1 plays an essential role in cell survival as an antioxidant protein, the function of GLRX1 protein in inflammatory response is still under investigation. Therefore, we wanted to know whether transduced PEP-1-GLRX1 protein inhibits lipopolysaccharide (LPS)- and 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced inflammation. In LPS-exposed Raw 264.7 cells, PEP-1-GLRX1 inhibited cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), activation of mitogen activated protein kinases (MAPKs) and nuclear factor-kappaB (NF-κB) expression levels. In a TPA-induced mouse-ear edema model, topically applied PEP-1-GLRX1 transduced into ear tissues and significantly ameliorated ear edema. Our data reveal that PEP-1-GLRX1 attenuates inflammation in vitro and in vivo, suggesting that PEP-1-GLRX1 may be a potential therapeutic protein for inflammatory diseases. [BMB Reports 2020; 53(2): 106-111].</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shin</LastName>
<ForeName>Min Jea</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Dae Won</ForeName>
<Initials>DW</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Yeon Joo</ForeName>
<Initials>YJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cha</LastName>
<ForeName>Hyun Ju</ForeName>
<Initials>HJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Sung Ho</ForeName>
<Initials>SH</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252; Genesen Inc., Seoul 06181, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>Jinseu</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Han</LastName>
<ForeName>Kyu Hyung</ForeName>
<Initials>KH</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eum</LastName>
<ForeName>Won Sik</ForeName>
<Initials>WS</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Soo Young</ForeName>
<Initials>SY</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Korea (South)</Country>
<MedlineTA>BMB Rep</MedlineTA>
<NlmUniqueID>101465334</NlmUniqueID>
<ISSNLinking>1976-6696</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D052246">Cyclooxygenase 2 Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054477">Glutaredoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C503924">Pep-1 peptide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>5UX2SD1KE2</RegistryNumber>
<NameOfSubstance UI="D003543">Cysteamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.13.39</RegistryNumber>
<NameOfSubstance UI="D052247">Nitric Oxide Synthase Type II</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.99.1</RegistryNumber>
<NameOfSubstance UI="D051546">Cyclooxygenase 2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>NI40JAQ945</RegistryNumber>
<NameOfSubstance UI="D013755">Tetradecanoylphorbol Acetate</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051546" MajorTopicYN="N">Cyclooxygenase 2</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052246" MajorTopicYN="N">Cyclooxygenase 2 Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003543" MajorTopicYN="N">Cysteamine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004487" MajorTopicYN="N">Edema</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054477" MajorTopicYN="N">Glutaredoxins</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052247" MajorTopicYN="N">Nitric Oxide Synthase Type II</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010455" MajorTopicYN="Y">Peptides</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000067996" MajorTopicYN="N">RAW 264.7 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013755" MajorTopicYN="N">Tetradecanoylphorbol Acetate</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2019</Year>
<Month>07</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>1</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>6</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>1</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31964467</ArticleId>
<ArticleId IdType="pii">4702</ArticleId>
<ArticleId IdType="pmc">PMC7061214</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Biomol Ther (Seoul). 2012 Jul;20(4):380-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24009824</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Eye Res. 2009 Dec;89(6):833-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19664619</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Biotechnol. 2001 Dec;19(12):1173-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11731788</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2011 Sep;1813(9):1619-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21167873</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Pharm Bull. 2018;41(8):1219-1227</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30068871</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Complement Altern Med. 2016 Jul 15;16:219</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27422559</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Pharm Des. 2005;11(28):3597-611</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16305497</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Agric Food Chem. 2011 Mar 9;59(5):2062-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21322561</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Biotechnol. 2011 Dec;22(6):888-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21489777</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Fish Shellfish Immunol. 2019 Mar;86:280-286</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30448447</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Molecules. 2018 Jul 27;23(8):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30060484</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Free Radic Biol Med. 2019 May 1;135:68-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30818058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Pharmacol. 2014 Feb 5;724:168-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24361309</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncol Res. 2005;15(7-8):333-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16491951</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2014 Jun;1840(6):1686-700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24412329</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biometals. 2014 Aug;27(4):661-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24816595</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Free Radic Biol Med. 2014 Apr;69:181-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24440593</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMB Rep. 2018 Jul;51(7):362-367</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29936932</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anal Biochem. 1976 May 7;72:248-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">942051</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Cell Mol Biol. 2007 Feb;36(2):147-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16980552</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Pathol. 2004 Aug;35(8):1000-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15297967</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Med Rep. 2018 Aug;18(2):2216-2228</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29916538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2002 Apr;160(4):1325-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11943717</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):281-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16101534</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2008 Jul 24;454(7203):428-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18650913</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Jan 23;9(1):e86034</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24465855</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Immunopharmacol. 2016 Sep;38:349-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27351825</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chin J Nat Med. 2018 Jul;16(7):481-489</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30080646</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Lung Cell Mol Physiol. 2010 Aug;299(2):L192-203</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20472709</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Immunopharmacol. 2014 Jun;20(2):298-306</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24735815</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2013 Sep;13(9):679-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23954936</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Cell Mol Biol. 2011 Apr;44(4):491-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20539014</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Pharm Res. 2015 Jun;38(6):1238-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25311664</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMB Rep. 2018 Oct;51(10):538-543</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30269741</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Immunopharmacol. 2015 Sep;28(1):136-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26054879</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2004 Mar;6(3):189-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15039791</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biometals. 2018 Feb;31(1):61-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29168020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Cell Cardiol. 2008 Feb;44(2):261-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17976641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMB Rep. 2018 Dec;51(12):654-659</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30545441</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomaterials. 2013 Nov;34(33):8075-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23891083</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1483-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11557676</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Immunopharmacol. 2018 Feb;55:312-322</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29310107</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Complement Altern Med. 2018 Jul 25;18(1):224</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30045725</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2009 Feb 20;284(8):4760-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19074435</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Skin Pharmacol. 1991;4(4):262-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1789987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mediators Inflamm. 2013;2013:619523</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24058272</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13086-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16916935</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antioxid Redox Signal. 2007 Nov;9(11):2027-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17845131</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2004 Jun 25;304(5679):1963-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15218148</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem J. 2013 Aug 15;454(1):147-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23751120</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Biotechnol. 2002 Feb;13(1):52-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11849958</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomaterials. 2015 Sep;64:45-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26117230</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2008 Nov;1780(11):1304-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18621099</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Pharmacol. 2015 Jan 15;747:45-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25281205</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Corée du Sud</li>
</country>
<region>
<li>Région capitale de Séoul</li>
</region>
<settlement>
<li>Séoul</li>
</settlement>
</list>
<tree>
<country name="Corée du Sud">
<noRegion>
<name sortKey="Shin, Min Jea" sort="Shin, Min Jea" uniqKey="Shin M" first="Min Jea" last="Shin">Min Jea Shin</name>
</noRegion>
<name sortKey="Cha, Hyun Ju" sort="Cha, Hyun Ju" uniqKey="Cha H" first="Hyun Ju" last="Cha">Hyun Ju Cha</name>
<name sortKey="Choi, Soo Young" sort="Choi, Soo Young" uniqKey="Choi S" first="Soo Young" last="Choi">Soo Young Choi</name>
<name sortKey="Choi, Yeon Joo" sort="Choi, Yeon Joo" uniqKey="Choi Y" first="Yeon Joo" last="Choi">Yeon Joo Choi</name>
<name sortKey="Eum, Won Sik" sort="Eum, Won Sik" uniqKey="Eum W" first="Won Sik" last="Eum">Won Sik Eum</name>
<name sortKey="Han, Kyu Hyung" sort="Han, Kyu Hyung" uniqKey="Han K" first="Kyu Hyung" last="Han">Kyu Hyung Han</name>
<name sortKey="Kim, Dae Won" sort="Kim, Dae Won" uniqKey="Kim D" first="Dae Won" last="Kim">Dae Won Kim</name>
<name sortKey="Lee, Sung Ho" sort="Lee, Sung Ho" uniqKey="Lee S" first="Sung Ho" last="Lee">Sung Ho Lee</name>
<name sortKey="Park, Jinseu" sort="Park, Jinseu" uniqKey="Park J" first="Jinseu" last="Park">Jinseu Park</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000035 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000035 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    GlutaredoxinV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31964467
   |texte=   PEP-1-GLRX1 protein exhibits anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB pathways in Raw 264.7 cells.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31964467" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GlutaredoxinV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 15:13:42 2020. Site generation: Wed Nov 18 15:16:12 2020